Clinical Significance of Perioperative Minimal Residual Disease Detected by Circulating Tumor DNA in Patients With Lung Cancer With a Long Follow-up Data: An Exploratory Study

Introduction: Molecular residual disease detected by circulating tumor DNA (ctDNA) has been reported to be predictive of patients’ outcomes in various types of cancers after curative intent treatment. Nevertheless, additional detailed information regarding the association of longitudinal ctDNA detec...

Full description

Saved in:

Bibliographic Details
Main Authors:	Shuta Ohara, MD, PhD, Kenichi Suda, MD, PhD, Sumedha Sudhaman, PhD, Akira Hamada, MD, PhD, Masato Chiba, MD, PhD, Masaki Shimoji, MD, PhD, Toshiki Takemoto, MD, PhD, Ekaterina Kalashnikova, PhD, Samantha K. Cheung, PhD, Michael Krainock, MD, PhD, Jordan Feeney, BS, Himanshu Sethi, MPH, Minetta C. Liu, MD, Junichi Soh, MD, PhD, Yasuhiro Tsutani, MD, PhD, Tetsuya Mitsudomi, MD, PhD
Format:	Article
Language:	English
Published:	Elsevier 2025-03-01
Series:	JTO Clinical and Research Reports
Subjects:	Circulating tumor DNA (ctDNA) Tumor informed approach Non-small cell lung cancer (NSCLC) Prognostic factor Recurrence-free survival (RFS) Disease monitoring
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666364324001322
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Clinical Significance of Perioperative Minimal Residual Disease Detected by Circulating Tumor DNA in Patients With Lung Cancer With a Long Follow-up Data: An Exploratory Study

Similar Items